Accelerate Diagnostics (AXDX) Posts Smaller Q1 Loss

Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.9 million.

Net cash used in the quarter was $13.2 million, and the company ended the quarter with total cash, investments, and cash equivalents of $50.4 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c